https://finanza.repubblica.it/Company/?symbol=1RVMD:IM
REVOLUTION MEDICINES INC - Scheda - Economia e Finanza - Repubblica.it
1RVMD:IM: ultimo valore, variazione, variazione percentuale, beta, grafico, ultime notizie
economia e finanzarevolution medicinesincschedarepubblica
https://www.stocks2buy.net/newsitems/revolution-medicines-(rvmd)-soars-on-pancreatic-cancer-drug-success-and-analyst-upgrades
Revolution Medicines (RVMD) Soars on Pancreatic Cancer Drug Success and Analyst Upgrades
revolution medicinespancreatic canceranalyst upgradesrvmddrug
https://retailpressreleases.com/article/910920667-revolution-medicines-announces-publication-in-new-england-journal-of-medicine-of-phase-1-2-clinical-data-on-daraxonrasib-in-pancreatic-cancer
Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical...
Retail Press Releases is an online news publication focusing on consumer goods in the World: News on retail in the world
revolution medicinesnew englandannouncespublicationjournal
https://www.chemdiv.com/company/media/pharma-news/2021/revolution-medicines-announces-dosing-of-first-patient-in-phase-1-1b-clinical-study-of-rmc-5552-in-patients-with-advanced-solid-tumors/
Revolution Medicines Announces Dosing of First Patient in Phase 1/1b Clinical...
Revolution Medicines Announces Dosing of First Patient in Phase 1/1b Clinical Study of RMC-5552 in Patients with Advanced Solid Tumors
revolution medicinesannouncesdosingfirstpatient
https://www.patentbots.com/patentverse/company/Revolution-Medicines-Inc.
Revolution Medicines, Inc.
Patent Bots Quality Scores are computed using one year of issued patents. See how patent law firms and companies rank for patent quality.
revolution medicinesinc
https://www.telecommunicationspressreleases.com/article/910895665-revolution-medicines-reports-first-quarter-2026-financial-results-and-update-on-corporate-progress
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress...
Telecommunications Press Releases is an online news publication focusing on industries in the World: The latest telecommunications news from the world
revolution medicinesfirst quarterfinancial resultsreportsupdate
https://www.dcatvci.org/top-industry-news/oncology-drug-company-revolution-medicines-seeks-to-raise-2-billion/
Oncology Drug Company Revolution Medicines Seeks To Raise $2 Billion - DCAT Value Chain Insights
Apr 16, 2026 - Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for treating RAS-addicted cancers, is seeking to raise $2 billion...
drug companyrevolution medicinesvalue chainoncologyseeks
https://www.panabee.com/news/revolution-medicines-earnings-q1-2026-report
Revolution Medicines Earnings Q1 2026 - Report | RVMD News & Analysis
Phase 3 trial success in PDAC provides clinical validation, while $2.1 billion in new capital secures development runway against an $1.8 billion annual burn...
revolution medicinesnews analysisearningsreportrvmd
https://www.cmlviz.com/stocks/RVMD
RVMD - Revolution Medicines Inc Quote, Price, Charts & News - CMLViz.com
RVMD Stock Price | Revolution Medicines Inc(XNAS:RVMD) stock summaries, charts and news
revolution medicinesprice chartsrvmdincquote
https://companieslogo.com/revolution-medicines/logo/
Revolution Medicines logo in transparent PNG and vectorized SVG formats
Download the logo of Revolution Medicines , in PNG and SVG format
revolution medicinestransparent pnglogosvgformats
https://www.talk.bio/2026/04/revolution-medicines-daraxonrasib.html
Revolution Medicines' Daraxonrasib Doubles Survival in Phase 3 Pancreatic Cancer Trial
revolution medicinespancreatic cancerdaraxonrasibdoublessurvival
https://public.com/stocks/rvmd/options-chain?expiration=2027-01-15
Buy Revolution Medicines (RVMD) Call and Put Options - Options Chain
revolution medicinesoptions chainbuyrvmdcall
https://wealthx.com/daily-news/merck-in-talks-to-buy-drugmaker-revolution-medicines-for-up-to-32-billion
Merck In Talks To Buy Revolution Medicines For Up To $32 Billion - Wealth-X
Jan 9, 2026 - Read the full story here.
in talksto buyrevolution medicinesmerckbillion
https://cs.bulios.com/ticker/RVMDW
Revolution Medicines, Inc. Warrant (RVMDW) Stock | RVMDW Stock Price & Analysis - Bulios
Get the latest news and market analysis for Revolution Medicines, Inc. Warrant (RVMDW). Stay up-to-date on RVMDW Stock price and share price with Bulios....
revolution medicinesstock priceincwarrantanalysis
https://wealthyhood.com/en/stocks/rvmd.nasdaq/
RVMD Stock Price | Revolution Medicines Inc P/E, Revenue, EPS, & Forecasts
Get the latest Revolution Medicines Inc stock quote with real-time price, P/E, EPS, Market Cap, and more. Stay updated with Revolution Medicines Inc news and...
stock pricerevolution medicinesrvmdincrevenue
https://pancan.org/press-releases/pancan-statement-on-positive-overall-survival-results-from-revolution-medicines-phase-iii-trial/
PanCAN Statement on Positive Overall Survival Results from Revolution Medicines Phase III Trial -...
Apr 14, 2026 - The Pancreatic Cancer Action Network (PanCAN), the leading organization dedicated to advancing progress against pancreatic cancer, released a statement today...
phase iii trialresults fromrevolution medicinesstatementpositive
https://tickeron.com/blogs/revolution-medicines-rvmd-stock-surges-41-in-30-days-clinical-wins-and-what-s-ahead-13077/
Revolution Medicines (RVMD) Stock Surges +41% in 30 Days: Clinical Wins and What's Ahead
Revolution Medicines (RVMD) stock surged +41% over the past 30 days, primarily driven by positive topline results from a pancreatic cancer trial announced...
revolution medicinesrvmdstocksurgesdays
https://careers.ispe-casa.org/jobs/21826235/usc-revolution-medicines-health-economic-and-outcomes-research-heor-fellowship
USC-Revolution Medicines, Health Economic and Outcomes Research (HEOR) Fellowship in Redwood City,...
Exciting opportunity in Redwood City, CA for USC as a USC-Revolution Medicines, Health Economic and Outcomes Research (HEOR) Fellowship
revolution medicinesoutcomes researchredwood cityuschealth
https://notreload.xyz/xy/abbvie-to-acquire-revolution-medicines-for-20b/
AbbVie Denies Revolution Medicines Acquisition Talks
Jan 7, 2026 - AbbVie denies WSJ report of $20B+ Revolution Medicines acquisition talks. Stocks react as drugmaker refutes advanced merger discussions.
revolution medicinesacquisition talksabbviedenies
https://www.resumemate.io/jobs/excel-jobs-in-redwood-city/7e7a1e_revolutionmedicines_7695674003
Senior Total Rewards Analyst at Revolution Medicines | ResumeMate
Apply for Senior Total Rewards Analyst at Revolution Medicines in Redwood City, California, United States. Skills: Excel, Workday. Apply now on ResumeMate.
total rewardsrevolution medicinessenioranalyst
https://roxom.com/terminal/stock/RVMD
Roxom | RVMD - Revolution Medicines, Inc. Common Stock
Trade Revolution Medicines, Inc. Common Stock (RVMD) with Bitcoin on Roxom. Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES). View price charts, market...
revolution medicinescommon stockrvmdinc
https://www.revmed.com/?ref=strv.ghost.io
Revolution Medicines
Jan 13, 2025 - At Revolution Medicines our mission is to revolutionize treatment for patients with RAS-addicted cancers through targeted medicines.
revolution medicines
https://theorg.com/org/revolution-medicines?person=jeff-cislini
REVOLUTION Medicines | The Org
Revolution Medicines is an innovative and dynamic organization of experts working together to discover and develop new medicines for cancer patients.
revolution medicinesthe org
https://www.macrotrends.net/stocks/charts/RVMD/revolution-medicines/revenue
Revolution Medicines Revenue 2018-2025 | RVMD | MacroTrends
Revolution Medicines annual/quarterly revenue history and growth rate from 2018 to 2025. Revenue can be defined as the amount of money a company receives from...
revolution medicinesrevenuervmdmacrotrends
https://pharma.economictimes.indiatimes.com/news/pharma-industry/abbvie-denies-media-reports-of-talks-to-buy-revolution-medicines/126405090
AbbVie Denies Acquisition Talks with Revolution Medicines Amid Stock Volatility, ETPharma
AbbVie refutes claims of acquisition discussions with Revolution Medicines, causing significant stock fluctuations. Learn more about the implications for both...
acquisition talksrevolution medicinesabbviedeniesamid
https://www.renaissancecapital.com/ProfileNews/RVMD
RVMD IPO News - Revolution Medicines Stock News
News Stories regarding Revolution Medicines (RVMD) IPO - Renaissance Capital
ipo newsrevolution medicinesrvmdstock
https://www.el-balad.com/16911738
Revolution Medicines Announces Breakthrough in Pancreatic Cancer Treatment - El-Balad.com
Revolution Medicines has achieved a significant breakthrough in the treatment of metastatic pancreatic cancer. Their innovative pill, known as daraxonrasib,...
pancreatic cancer treatmentrevolution medicinesannouncesbreakthroughel
https://profiles.biocentury.com/companies/revolution_medicines_inc
Revolution Medicines Inc. - BioCentury Company Profiles - BCIQ
Revolution Medicines Inc. - BioCentury Company Profiles for the biopharma industry
revolution medicinescompany profilesinc
https://www.lw.com/en/news/2022/07/Latham%20Watkins%20Advises%20Revolution%20Medicines%20in%20its%20Million%20Public%20Offering
Latham Watkins Advises Revolution Medicines in its Million Public Offering
A multidisciplinary team advises the clinical-stage oncology company in the offering.
revolution medicinespublic offeringlathamwatkinsadvises
https://bullishdaily.com/news/revolution-medicines-daraxonrasib-pancreatic-cancer-breakthrough-2b-funding
Revolution Medicines' Daraxonrasib Doubles Survival in Pancreatic Cancer Trial, Secures $2B Funding...
Revolution Medicines' Phase 3 success with daraxonrasib in advanced pancreatic cancer, doubling median survival, triggers $2B raise, signaling investor...
revolution medicinespancreatic cancerdaraxonrasibdoublessurvival
https://cuspwealth.com/asset/RVMD
Revolution Medicines, Inc. Common Stock (RVMD) - Live Stock Price, Valuation & Analysis | CUSP...
Revolution Medicines, Inc. Common Stock (RVMD) shows live price, valuation strength, and dividend trends with key ratios and analyst insights for informed...
revolution medicinescommon stocklive pricevaluation analysisinc
https://kbjr.marketminute.com/article/marketminute-2026-3-31-gilead-sciences-acquires-ouro-medicines-for-22-billion-to-lead-immune-reset-revolution
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution |...
In a move that signals a decisive shift in the treatment of chronic autoimmune conditions, Gilead Sciences (NASDAQ:GILD) announced on March 23, 2026, its...
gilead sciencesouromedicinesbillionimmune